Concepedia

Eva Revilla‐López

ER

Statistics

Publications

6

Citations

172

H-Index

6

Active since

2020

Affiliations

Instituto de Salud Carlos III(Current)

Vall d'Hebron Hospital Universitari

Institut d'Investigació Biomédica de Bellvitge

Bellvitge University Hospital

Centro de Investigación Biomédica en Red de Enfermedades Respiratorias

Eva Revilla‐López is an author at Instituto de Salud Carlos III specializing in allergy, apoptosis, and cell signaling.

ORCID

Top concepts

Publications per year

2020–2023

6

Publications

6

COVID-19 in lung transplant recipients: A multicenter study

Berta Sáez, Cristina Berastegui, Míriam Barrecheguren et al. · American Journal of Transplantation · 2020 · 73 citations · Full text

CMV-Specific Cell-Mediated Immunity Predicts a High Level of CMV Replication After Prophylaxis Withdrawal in Lung Transplant Recipients

Laura Donadeu, Eva Revilla‐López, Marta Jarque et al. · The Journal of Infectious Diseases · 2020 · 25 citations · Full text

Long-term results of sirolimus treatment in lymphangioleiomyomatosis: a single referral centre experience

Eva Revilla‐López, Cristina Berastegui, Alejandra Méndez et al. · Scientific Reports · 2021 · 22 citations · Full text

Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension

Alfredo Castillo, Manuel López‐Meseguer, Vicent Fonollosa‐Pla et al. · Scientific Reports · 2022 · 19 citations · Full text

Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis

Carmen Herranz, Francesca Mateo, Alexandra Baiges et al. · EMBO Molecular Medicine · 2021 · 18 citations · Full text

, , +12

1–5 of 6